Catalyst
Slingshot members are tracking this event:
JUVÉDERM VOLBELLA XC Approved By U.S. FDA For Use In Lips And Perioral Rhytids
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
AGN | Community voting in process |
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 01, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Juvederm Volbella Xc, Perioral Rhytids, Perioral Lines